Altimmune (NasdaqGM:ALT) Conference September 30, 2025 10:30 AM ET Company ParticipantsVipin K. Garg - CEOScott Harris - Chief Medical OfficerConference Call ParticipantsAnnabel Samimy - Managing Director and Senior Analyst in HealthcareAnnabel SamimyHi there, good morning and thanks for joining the Altimmune Session. I'm pleased to have with us CEO Vipin K. Garg and Chief Medical Officer Scott Harris with us today. As you all know, Altimmune has a GLP-1/GCG glucagon dual agonist being developed for MASH, w ...